$6.17
-0.120 (-1.91%)
At Close: Jul 31, 2026
Sanuwave Health (SNWV) Surges 9.1%: Is This an Indication of Further Gains?
06:41am, Tuesday, 07'th Oct 2025
Sanuwave Health (SNWV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more str
SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript
08:25pm, Monday, 06'th Oct 2025
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q3 2025 Earnings Call October 6, 2025 5:30 PM EDT Company Participants Morgan Frank - CEO & Chairman Conference Call Participants Kyle Bauser - ROTH Capital Partne
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
04:01pm, Monday, 06'th Oct 2025
Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history.
3 Lesser-Known Healthcare Names With Major Upside in Store
08:19am, Thursday, 02'nd Oct 2025
The global healthcare market is growing rapidly—it is expected to climb at a 6.9% CAGR over the next eight years, reaching more than $22.3 trillion by 2033. Its appeal to investors in the current ma
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
07:00am, Friday, 26'th Sep 2025
Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver have
SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
03:42pm, Friday, 08'th Aug 2025
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Morgan C. Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call P
Sanuwave (SNWV) Q2 Revenue Jumps 42%
06:22am, Friday, 08'th Aug 2025
Sanuwave (SNWV) Q2 Revenue Jumps 42%
Sanuwave Announces Q2 FY2025 Financial Results
06:00am, Friday, 08'th Aug 2025
Q2 2025 revenues were $10.2 million , up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history.
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
05:00pm, Monday, 04'th Aug 2025
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, wil
Sanuwave Health to Present at Canaccord Genuity Growth Conference
04:05pm, Tuesday, 22'nd Jul 2025
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Fran
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
01:13am, Wednesday, 11'th Jun 2025
Sanuwave's UltraMIST offers superior wound care, reducing costs and healing time for hospitals, making it attractive to both providers and insurers. Under new CEO Morgan Frank, Sanuwave has revitalize
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
07:30am, Tuesday, 03'rd Jun 2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is
Sanuwave Health Selected for Inclusion in Russell 2000® Index
04:10pm, Wednesday, 28'th May 2025
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 20
Sanuwave Health Appoints Greg Bazar to Board of Directors
04:05pm, Wednesday, 28'th May 2025
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is p
SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript
09:53pm, Friday, 09'th May 2025
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and CEO Peter Sorensen - CFO Conference Call Participants Carl
Sign In
Buy SNWV